EBNA-1 sequence variations reflect active EBV replication and disease status or quiescent latency in lymphocytes

Journal of Medical Virology

Volumn 69, Issue 3, 2003, Pages 417-425

  Wang, Jiin Tarng ^a   Sheeng, Tzung Shiahn ^b   Su, Ih Jen ^b   Chen, Jen Yang ^a,c   Chen, Mei Ru ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

EBNA 1; EBV; Sequence variation; Viral reactivation

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; VIRUS DNA;

ANTIGEN BINDING; ANTIGENIC VARIATION; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA SEQUENCE; EPSTEIN BARR VIRUS; GENE FREQUENCY; GEOGRAPHIC DISTRIBUTION; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; HUMAN TISSUE; METAPHASE; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRUS REPLICATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARCINOMA; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOCYTES; LYMPHOPROLIFERATIVE DISORDERS; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS); VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0037359884     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10305     Document Type: Article

References (30)

1. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
2. Berger C, McQuain C, Sullivan JL, Nadal D, Quesenberry PJ, Knecht H. 1997. The 30-bp deletion variant of Epstein-Barr virus-encoded latent membrane protein-1 prevails in acute infectious mononucleosis. J Infect Dis 176:1370-1373.
3. Bhatia K, Magrath I. 1999. EBNA-1 sequences in endemic and sporadic Burkitt's lymphoma. J Virol 73:7096-7097.
4. Bhatia K, Raj A, Guitiérrez MI, Judde JG, Spangler G, Venkatesh H, Magrath IT. 1996. Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 13:177-181.
5. Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, Liu ST, Chang YS. 1992. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131-2140.
6. Chen YY, Chang KL, Chen WG, Shibata D, Hayashi K, Weiss LM. 1998. Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma. Lab Invest 78:877-882.
7. Chen MR, Tsai CH, Wu FF, Kan SH, Yang CS, Chen JY. 1999. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines. J Gen Virol 80:447-455.
8. Chiang AK, Wong KY, Liang AC, Srivastava G. 1999. Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/NK-cell lymphomas and normal nasal tissues: implications on virus strain selection in malignancy. Int J Cancer 80:356-364.
9. Dambaugh T, Hennessy K, Chamnankit L, Kieff E. 1984. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 81:7632-7636.
10. Fan H, Gulley ML. 2001. Epstein-Barr viral load measurement as a marker of EBV-related disease. Mol Diagn 6:279-289.
11. Fielding CA, Sandvej K, Mehl A, Brennan P, Jones M, Rowe M. 2001. Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways. J Virol 75:9129-9141.
12. Gutiérrez MI, Raj A, Spangler G, Sharma A, Hussain A, Judde JG, Tsao SW, Yuen PW, Joab I, Magrath IT, Bhatia K. 1997. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumor cells. J Gen Virol 78:1663-1670.
13. Gutiérrez MI, Spangler G, Kingma D, Raffeld M, Guerrero I, Misad O, Jaffe ES, Magrath IT, Bhatia K. 1998. Epstein-Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene. Blood 92:600-606.
14. Habeshaw G, Yao QY, Bell Al, Morton D, Rickinson AB. 1999. Epstein-Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. J Virol 73:965-975.
15. Henry S, Sacaze C, Berrajah L, Karray H, Drira M, Hammami A, Icart J, Mariame B. 2001. In nasopharyngeal carcinoma-bearing patients, tumors and lymphocytes are infected by different Epstein-Barr virus strains. Int J Cancer 91:698-704.
16. Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G. 1991. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 72:2399-2409.
17. Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, Winberg G. 1993. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 8:1575-1583.
18. Khanim F, Yao QY, Niedobitek G, Sihota S, Rickinson AB, Young LS. 1996. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 88:3491-3501.
19. Leung SY, Yuen ST, Chung LP, Chan AS, Wong MP. 1997. Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese. Int J Cancer 72:225-230.
20. Niedobitek G. 2000. Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol Pathol 53:248-254.
21. Palefsky JM, Berline J, Greenspan D, Greenspan JS. 2002. Evidence for trafficking of Epstein-Barr virus strains between hairy leukoplakia and peripheral blood lymphocytes. J Gen Virol 83:317-321.
22. Rickinson AB, Kieff E. 2001. Epstein-Barr virus. In: Knipe DM, Howley PM, editors. Field's Virology. Philadelphia: Lippincott Williams and Wilkins. p 2575-2627.
23. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A. 1990. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 64:4084-4092.
24. Sandvej K, Zhou XG, Hamilton-Dutoit S. 2000. EBNA-1 sequence variation in Danish and Chinese EBV-associated tumours: evidence for geographical polymorphism but not for tumour-specific subtype restriction. J Pathol 191:127-131.
25. Sixbey JW, Shirley P, Chesney PJ, Buntin DM, Resnick L. 1989. Detection of a second widespread strain of Epstein-Barr virus. Lancet 2:761-765.
26. Snudden DK, Smith PR, Lai D, Ng MH, Griffin BE. 1995. Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours. Oncogene 10: 1545-1552.
27. Srivastava G, Wong KY, Chiang AK, Lam KY, Tao Q. 2000. Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state. Blood 95:2443-2445.
28. Wrightham MN, Stewart JP, Janjua NJ, Pepper SD, Sample C, Rooney CM, Arrand JR. 1995. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 208:521-530.
29. Wu SJ, Lay JD, Chen CL, Chen JY, Liu MY, Su IJ. 1996. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area. J Med Virol 50:314-321.
30. Yao QY, Rowe M, Martin B, Young LS, Rickinson AB. 1991. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J Gen Virol 72:1579-1590.